Patients with lupus with COVID-19: University of Michigan experience.
作者信息
Wallace Beth, Washer Laraine, Marder Wendy, Kahlenberg J Michelle
机构信息
Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Internal Medicine/Rheumatology, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
出版信息
Ann Rheum Dis. 2021 Mar;80(3):e35. doi: 10.1136/annrheumdis-2020-217794. Epub 2020 May 31.
Abstract
摘要
相似文献
1
Patients with lupus with COVID-19: University of Michigan experience.患有狼疮且感染新冠病毒的患者：密歇根大学的经验。
Ann Rheum Dis. 2021 Mar;80(3):e35. doi: 10.1136/annrheumdis-2020-217794. Epub 2020 May 31.
2
Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace .
Ann Rheum Dis. 2021 Mar;80(3):e36. doi: 10.1136/annrheumdis-2020-217910. Epub 2020 May 31.
3
Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort.羟氯喹治疗类风湿关节炎和系统性红斑狼疮患者对 COVID-19 发病风险的影响：一项多中心回顾性队列研究。
J Int Med Res. 2022 Apr;50(4):3000605221090363. doi: 10.1177/03000605221090363.
4
Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.羟氯喹可降低系统性红斑狼疮和类风湿关节炎患者的 Th17 相关细胞因子。
Clinics (Sao Paulo). 2013 Jun;68(6):766-71. doi: 10.6061/clinics/2013(06)07.
5
[ANTIMALARIALS IN THE TREATMENT OF CHROMIC INFLAMMATORY RHEUMATISM. (APROPOS OF A PERSONAL EXPERIENCE OF 142 CASES)].[抗疟药治疗慢性炎症性风湿病。（基于142例个人经验）]
Rhumatologie. 1964 Jun-Jul;16:271-9.
6
Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar .对霍卢巴尔所著《COVID-19疫情期间系统性红斑狼疮患者的监测》的回应
Ann Rheum Dis. 2021 Apr;80(4):e57. doi: 10.1136/annrheumdis-2020-217988. Epub 2020 Jun 8.
7
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
8
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
9
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Nov;82(11):e225. doi: 10.1136/annrheumdis-2021-220410. Epub 2021 Apr 21.
10
Risk of COVID-19 infection among lupus erythematosus patients and rheumatoid arthritis patients: a retrospective study in Hubei, China.红斑狼疮患者和类风湿关节炎患者中新型冠状病毒肺炎感染风险：中国湖北的一项回顾性研究
Eur J Dermatol. 2020 Dec 1;30(6):751-753. doi: 10.1684/ejd.2020.3926.
引用本文的文献
1
Peripheral Blood Mononuclear Cells and Serum Cytokines in Patients with Lupus Nephritis after COVID-19.COVID-19 后狼疮肾炎患者外周血单个核细胞和血清细胞因子。
Int J Mol Sci. 2024 Jul 29;25(15):8278. doi: 10.3390/ijms25158278.
2
COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study.贝利尤单抗治疗的系统性红斑狼疮患者中的新型冠状病毒肺炎：一项回顾性临床研究。
Immunol Res. 2024 Jun;72(3):418-429. doi: 10.1007/s12026-023-09449-2. Epub 2023 Dec 22.
3
Systemic lupus erythematosus nephritis and COVID-19 disease.系统性红斑狼疮肾炎与 COVID-19 疾病。
Clin Rheumatol. 2023 Sep;42(9):2335-2340. doi: 10.1007/s10067-023-06634-4. Epub 2023 May 17.
4
Systemic Lupus Erythematosus and Coronavirus Disease 2019.系统性红斑狼疮与2019冠状病毒病
Rheumatol Immunol Res. 2021 Apr 13;2(1):15-18. doi: 10.2478/rir-2021-0004. eCollection 2021 Mar.
5
A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与自身免疫性疾病的综述：有何关联？
Life (Basel). 2022 Nov 18;12(11):1918. doi: 10.3390/life12111918.
6
Humoral and cellular response in convalescent COVID-19 lupus patients.恢复期 COVID-19 狼疮患者的体液和细胞反应。
Sci Rep. 2022 Aug 12;12(1):13787. doi: 10.1038/s41598-022-17334-5.
7
COVID-19 in patients with systemic lupus erythematosus: A systematic review.COVID-19 与系统性红斑狼疮：系统综述。
Lupus. 2022 May;31(6):684-696. doi: 10.1177/09612033221093502. Epub 2022 Apr 5.
8
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.COVID-19 患者狼疮短期结局的研究：全国多中心研究网络的倾向评分匹配分析。
J Autoimmun. 2021 Dec;125:102730. doi: 10.1016/j.jaut.2021.102730. Epub 2021 Oct 9.
9
Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.系统性红斑狼疮患者新冠病毒肺炎住院率：丹麦全国队列研究
J Clin Med. 2021 Aug 27;10(17):3842. doi: 10.3390/jcm10173842.
10
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review.2019年冠状病毒病大流行期间风湿性自身免疫性疾病的流行病学与临床管理：综述
Front Med (Lausanne). 2021 Aug 19;8:725226. doi: 10.3389/fmed.2021.725226. eCollection 2021.
本文引用的文献
1
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
Zotero 插件